Viridans Streptococci Bacteremia

The results of this field of study indicate that the combined use of clarithromycin 500mg and ciprofloxacin has the possibility to significantly reduce the occurrent of viridans streptococcal bacteremia.
Patients in unit 4, who received this collection of prophylactic device antibiotics, presented a significant lessening in the optical phenomenon of S viridans, compared with the other groups.
More than 90% of S viridans isolates are susceptible to the newer macrolides, such as clarithromycin.
This is a part of article Viridans Streptococci Bacteremia Taken from "Generic Colospa (Mebeverine) Portal" Information Blog